Nicholas Baxter - May 7, 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Nicholas Baxter/
Stock symbol
LEXX
Transactions as of
May 7, 2021
Transactions value $
$0
Form type
4
Date filed
6/9/2021, 11:23 AM
Next filing
Jun 9, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 11K May 7, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Other $0 -5K -76.92% $0.00 1.5K May 7, 2021 Common Shares 5K $9.60 Direct F1
holding LEXX Stock Options 5K May 7, 2021 Common Shares 5K $9.60 Direct
holding LEXX Stock Options 6.5K May 7, 2021 Common Shares 1.5K $5.31 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cancellation of Options